| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| A655732-1ml | 1ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $440.90 |
| Specifications & Purity | 10mM in DMSO |
|---|---|
| Storage Temp | Store at -80°C |
| Shipped In | Ice chest + Ice pads |
| Product Description | AZD-9574 is a potent and brain penetrant PARP1 inhibitor and shows >8000-fold selectivity for PARP1 compared to PARP2/3/5a/6. AZD-9574 acts by selectively inhibiting and trapping PARP1 at the sites of SSBs. AZD-9574 is an anti-cancer agent and can be used for HRD + breast cancer and advanced solid malignancies research In Vitro AZD-9574 inhibits PARP1 enzymatic activity with IC 50 s range between 0.3-2 nM in all tested cell lines irrespective of the homologous recombination repair (HRR) status. In isogenic cell lines pairs confirms higher potency and selectivity towards HRR-deficient (HRD + ) models (DLD1 BRCA2 -/- ; SKOV-3 BRCA2 -/- and SKOV-3 PALB2 -/- ). The IC 50 in BRCA2 -/- DLD1 cells is 1.38 nM compared to IC 50 >40 µM BRCA2 wt cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo AZD-9574 (3 mg/kg) shows sustained tumour growth suppression resulting in a significantly extended survival of tumour-bearing mice, in intracranial xenograft model of breast cancer brain metastases . MCE has not independently confirmed the accuracy of these methods. They are for reference only. IC50& Target:PPAR |
| Canonical SMILES | O=C(C1=NC(F)=C(N2CCN(CC2)CC3=C(F)C4=C(N=C(C)C(N4)=O)C=C3)C=C1)NC |
|---|---|
| Molecular Weight | 428.44 |
Enter Lot Number to search for COA:
